These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9216837)

  • 1. Synthesis and cellular uptake of 2'-substituted analogues of (E)-5-(2-[125I]iodovinyl)-2'-deoxyuridine in tumor cells transduced with the herpes simplex type-1 thymidine kinase gene. Evaluation as probes for monitoring gene therapy.
    Morin KW; Atrazheva ED; Knaus EE; Wiebe LI
    J Med Chem; 1997 Jul; 40(14):2184-90. PubMed ID: 9216837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel (E)-5-(2-iodovinyl)-2'-deoxyuridine derivatives as potential cytostatic agents against herpes simplex virus thymidine kinase gene transfected tumors.
    Balzarini J; Morin KW; Knaus EE; Wiebe LI; De Clercq E
    Gene Ther; 1995 Jul; 2(5):317-22. PubMed ID: 7671107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Seno T
    Mol Pharmacol; 1985 Dec; 28(6):581-7. PubMed ID: 3001499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human osteosarcoma cell line expressing herpes simplex type-1 thymidine kinase: studies with radiolabeled (E)-5-(2-iodovinyl)-2'-fluoro-2'-deoxyuridine.
    Morin KW; Duan W; Knaus EE; McEwan AJ; Wiebe LI
    Nucl Med Biol; 2005 Jul; 32(5):459-64. PubMed ID: 15982576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
    Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity and cellular uptake of pyrimidine nucleosides for imaging herpes simplex type-1 thymidine kinase (HSV-1 TK) expression in mammalian cells.
    Morin KW; Duan W; Xu L; Zhou A; Moharram S; Knaus EE; McEwan AJ; Wiebe LI
    Nucl Med Biol; 2004 Jul; 31(5):623-30. PubMed ID: 15219281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reporter gene imaging: effects of ganciclovir treatment on nucleoside uptake, hypoxia and perfusion in a murine gene therapy tumour model that expresses herpes simplex type-1 thymidine kinase.
    Morin KW; Knaus EE; Wiebe LI; Xia H; McEwan AJ
    Nucl Med Commun; 2000 Feb; 21(2):129-37. PubMed ID: 10758606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
    Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
    Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
    Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
    J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene-transfected tumor cells.
    Balzarini J; Bohman C; Walker RT; de Clercq E
    Mol Pharmacol; 1994 Jun; 45(6):1253-8. PubMed ID: 8022417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of the penciclovir analog 9-(4-[(18)F]fluoro-3-hydroxymethylbutyl)guanine for in vivo measurement of suicide gene expression with PET.
    Alauddin MM; Shahinian A; Gordon EM; Bading JR; Conti PS
    J Nucl Med; 2001 Nov; 42(11):1682-90. PubMed ID: 11696640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Fluoro-1-(2'-deoxy-2'-fluoro-beta-D-ribofuranosyl) uracil trapping in Morris hepatoma cells expressing the herpes simplex virus thymidine kinase gene.
    Germann C; Shields AF; Grierson JR; Morr I; Haberkorn U
    J Nucl Med; 1998 Aug; 39(8):1418-23. PubMed ID: 9708520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo comparison of IVDU and IVFRU in HSV1-TK gene expressing tumor bearing rats.
    Choi TH; Ahn SH; Kwon HC; Choi CW; Awh OD; Lim SM
    Appl Radiat Isot; 2004 Jan; 60(1):15-21. PubMed ID: 14687631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of HSV-1 TK gene-transfected murine mammary carcinoma cells resistant to (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and ganciclovir (GCV).
    Degrève B; De Clercq E; Balzarini J
    Gene Ther; 2000 Sep; 7(18):1543-52. PubMed ID: 11021592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiviral activity of IVFRU, a potential probe for the non-invasive diagnosis of herpes simplex encephalitis.
    Iwashina T; Tovell DR; Xu L; Tyrrell DL; Knaus EE; Wiebe LI
    Drug Des Deliv; 1988 Dec; 3(4):309-21. PubMed ID: 2855580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-alkynyl analogs of arabinouridine and 2'-deoxyuridine: cytostatic activity against herpes simplex virus and varicella-zoster thymidine kinase gene-transfected cells.
    Cristofoli WA; Wiebe LI; De Clercq E; Andrei G; Snoeck R; Balzarini J; Knaus EE
    J Med Chem; 2007 Jun; 50(12):2851-7. PubMed ID: 17518459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs.
    Wildner O; Hoffmann D; Jogler C; Uberla K
    Cancer Gene Ther; 2003 Oct; 10(10):791-802. PubMed ID: 14502232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the incorporation of (E)-5-(2-iodovinyl)-2'-deoxyuridine and its carbocyclic analogue into DNA of herpes simplex virus type 1-infected cells in the antiviral effects of these compounds.
    Balzarini J; Bernaerts R; Verbruggen A; De Clercq E
    Mol Pharmacol; 1990 Mar; 37(3):402-7. PubMed ID: 2156154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of (E)-5-(2-iodovinyl)-2'-deoxyuridine into deoxyribonucleic acids of varicella-zoster virus (TK+ and TK- strains)-infected cells.
    Yokota T; Konno K; Shigeta S; Verbruggen A; De Clercq E
    Mol Pharmacol; 1987 May; 31(5):493-9. PubMed ID: 3033468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.